Bornstein Yoseph 4/A
4/A · Microbot Medical Inc. · Filed Oct 21, 2020
Insider Transaction Report
Form 4/AAmended
Bornstein Yoseph
Director10% Owner
Transactions
- Sale
Common Stock
2020-10-12$7.84/sh−20,000$156,898→ 246,909 total(indirect: By LSA- LifeScience Accelerator Ltd.)
Footnotes (3)
- [F1]The original Form 4 filed on October 13, 2020 is amended by this Form 4 amendment to correctly reflect the transaction date in Table 1, Item 2. No other changes have been made to the original Form 4.
- [F2]Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 12, 2020. Accordingly, Reporting Person beneficially owned 246,909 shares of Issuer common stock following the reported transactions.
- [F3]Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.